Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

February 27, 2024

Baseimmune secures funding for vaccine development

Baseimmune, a biotech firm specialising in artificial intelligence (AI)-driven vaccine development, has announced the successful closure of a £9m Series A funding round.

Baseimmune secures funding for vaccine development